Pfizer Australia Pty Ltd—Halcion, Ponstan and Xanax

PRA number

2015/14593

Published date

Product description

Prescription medications
Identifying features
HALCION (triazolam) & PONSTAN (mefenamic acid) & XANAX (alprazolam) - All Batches HALCION (triazolam) 0.125 mg tablets, Bottles of 50 AUST R number: 12304 PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50 AUST R number: 14387 XANAX (alprazolam) 2mg Tablets, Bottles of 50 AUST R number: 53931 (Discontinued December 2013)

Other identifying numbers

HALCION (triazolam) & PONSTAN (mefenamic acid) & XANAX (alprazolam) - All Batches

HALCION (triazolam) 0.125 mg tablets, Bottles of 50 AUST R number: 12304

PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50 AUST R number: 14387

XANAX (alprazolam) 2mg Tablets, Bottles of 50 AUST R number: 53931 (Discontinued December 2013)

What are the defects?

The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.

What are the hazards?

If children gain access to the products there is the potential for inadvertent poisoning.

What should consumers do?

Consumers are asked to consult their physician on an alternate treatment and then return the product to the place of purchase for a full refund.

Supplier

Pfizer Australia Pty Ltd

Traders who sold this product

Various Pharmacies nationwide

Where the product was sold

Nationally

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Pharmacy